Lower urinary tract obstruction (LUTO) comprises a heterogeneous group of pathologies associated with early-onset oligohydramnios and cystic renal disease that have high rates of perinatal morbidity (from renal disease) and mortality (from pulmonary hypoplasia). The use of prenatal detailed ultrasonography and fetal urine analysis has been only partially successful in identifying fetuses with LUTO with relatively good prognosis that would benefit from in utero therapy. The most common prenatal therapy is vesicoamniotic shunting. Newer techniques, such as fetal cystoscopy, have potential for enhancing prenatal triage and simultaneously delivering treatment. Vesicoamniotic shunting seems to improve perinatal survival, but whether this treatment or conservative management is used, the surviving children have a high rate of end-stage renal failure requiring dialysis and transplantation. Further investigation of long-term outcomes of vesicoamniotic shunting and fetal cystoscopy is hoped to delineate the risks and benefits of these prenatal treatments and inform management strategies.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Maternal Health, Neonatology and Perinatology Open Access 18 November 2015
Subscribe to Journal
Get full journal access for 1 year
only $6.58 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Lewis, M. A. Demography of renal disease in childhood. Semin. Fetal Neonatal Med. 13, 118–124 (2008).
Sarhan, O. et al. Long-term outcome of prenatally detected posterior urethral valves: single center study of 65 cases managed by primary valve ablation. J. Urol. 179, 307–312 (2008).
Ylinen, E., Ala-Houhala, M. & Wikström, S. Prognostic factors of posterior urethral valves and the role of antenatal detection. Pediatr. Nephrol. 19, 874–879 (2004).
Parkhouse, H. F. et al. Long-term outcome of boys with posterior urethral valves. Br. J. Urol. 62, 59–62 (1988).
Anumba, D. O., Scott J. E., Plant, N. D. & Robson S. C. Diagnosis and outcome of fetal lower urinary tract obstruction in the northern region of England. Prenat. Diagn. 25, 7–13 (2005).
Malin G., Tonks, A. M., Morris R. K., Gardosi J. & Kilby, M. D. Congenital lower urinary tract obstruction: a population-based epidemiological study. BJOG 119, 1455–1464 (2012).
Knox, W. F. & Barson, A. J. Pulmonary hypoplasia in a regional perinatal unit. Early Hum. Dev. 14, 33–42 (1986).
Liao, A. W., Sebire, N. J., Geerts, L., Cicero, S. & Nicolaides, K. H. Megacystis at 10–14 weeks of gestation: chromosomal defects and outcome according to bladder length. Ultrasound Obstet. Gynecol. 21, 338–341 (2003).
Montemarano, H., Bulas, D. I., Rushton, H. G. & Selby, D. Bladder distension and pyelectasis in the male fetus: causes, comparisons, and contrasts. J. Ultrasound Med. 17, 743–749 (1998).
Yiee, J. & Wilcox, D. Abnormalities of the fetal bladder. Semin. Fetal Neonatal Med. 13, 164–170 (2008).
Wickstrom, E. A., Thangavelu, M., Parilla, B. V., Tamura, R. K. & Sabbagha, R. E. A prospective study of the association between isolated fetal pyelectasis and chromosome abnormality. Obstet. Gynecol. 88, 379–382 (1996).
Favre R., Kohler, M., Gasser, B., Muller, F. & Nisand, I. Early fetal megacystis between 11 and 15 weeks of gestation. Ultrasound Obstet. Gynecol. 14, 402–406 (1999).
Weber, S. et al. Muscarinic acetylcholine receptor M3 mutation causes urinary bladder disease and a prune-belly-like syndrome. Am. J. Hum. Genet. 89, 668–674 (2011).
Morris, R. K., Malin G. L., Khan, K. S. & Kilby, M. D. Antenatal ultrasound to predict postnatal renal function in congenital lower urinary tract obstruction: systematic review of test accuracy. BJOG 116, 1290–1299 (2009).
Thomas, D. F. Prenatally diagnosed urinary tract abnormalities: long-term outcome. Semin. Fetal Neonatal Med. 13, 189–195 (2008).
Bernardes, L. S., Salomon, R., Aksnes, G., Lortat-Jacob, S. & Benachi, A. Ultrasound evaluation of prognosis in fetuses with posterior urethral valves. J. Pediatr. Surg. 46, 1412–1418 (2011).
Johnson, M. P. et al. In utero surgical treatment of fetal obstructive uropathy: a new comprehensive approach to identify appropriate candidates for vesicoamniotic shunt therapy. Am. J. Obstet. Gynecol. 170, 1770–1776 (1994).
Johnson, M. P. et al. Sequential urinalysis improves evaluation of fetal renal function in obstructive uropathy. Am. J. Obstet. Gynecol. 173, 59–65 (1995).
Muller, F. et al. Fetal urinary biochemistry predicts postnatal renal function in children with bilateral obstructive uropathies. Obstet. Gynecol. 82, 813–820 (1993).
Dommergues, M. et al. Fetal serum β2-microglobulin predicts postnatal renal function in bilateral uropathies. Kidney Int. 58, 312–316 (2000).
Morris R. K., Quinlan-Jones, E., Kilby, M. D. & Khan, K. S. Systematic review of accuracy of fetal urine analysis to predict poor postnatal renal function in cases of congenital urinary tract obstruction. Prenat. Diagn. 27, 900–911 (2007).
Klein, J. et al. Fetal urinary peptides to predict postnatal outcome of renal disease in fetuses with posterior urethral valves (PUV). Sci. Transl. Med. 5, 198ra106 (2013).
Harrison, M. R. & Filly, R. A. in The Unborn Patient: Prenatal diagnosis and treatment 2nd edn (eds Harrison, M. R., Goldbus, M. & Filly, R. A.) 328–402 (Saunders, 1990).
Harrison, M. R., Nakayama, D. K., Noall, R. & de Lorimier, A. A. Correction of congenital hydronephrosis in utero II. Decompression reverses the effects of obstruction of the fetal lung and urinary tract. J. Pediatr. Surg. 17, 965–974 (1982).
Glick, P. L., Harrison, M. R., Noall, R. A. & Villa, R. L. Correction of congenital hydronephrosis in utero III. Early mid-trimester ureteral obstruction produces renal dysplasia. J. Pediatr. Surg. 18, 681–687 (1983).
Harrison, M. R., Ross, N., Noall, R. & de Lorimier, A. A. Correction of congenital hydronephrosis in utero I. The model: fetal urethral obstruction produces hydronephrosis and pulmonary hypoplasia in fetal lambs. J. Pediatr. Surg. 18, 247–256 (1983).
Crombleholme, T. M. et al. Early experience with open fetal surgery for congenital hydronephrosis. J. Pediatr. Surg. 23, 1114–1121 (1988).
Clifton, M. S., Harrison, M. R., Ball, R. & Lee, H. Fetoscopic transuterine release of posterior urethral valves: a new technique. Fetal Diagn. Ther. 23, 89–94 (2008).
Manning, F. A., Harrison, M. R. & Rodeck, C. Catheter shunts for fetal hydronephrosis and hydrocephalus. Report of the International Fetal Surgery Registry. N. Engl. J. Med. 315, 336–340 (1986).
Morris, R. K., Malin G. L., Khan, K. S. & Kilby, M. D. Systematic review of the effectiveness of antenatal intervention for the treatment of congenital lower urinary tract obstruction. BJOG 117, 382–390 (2010).
Clark, T. J. et al. Prenatal bladder drainage in the management of fetal lower urinary tract obstruction: a systematic review and meta-analysis. Obstet. Gynecol. 102, 367–382 (2003).
Clayton, D. B. & Brock, J. W. 3rd. In utero intervention for urologic diseases. Nat. Rev. Urol. 9, 207–217 (2012).
Quintero, R. A. et al. In-utero percutaneous cystoscopy in the management of fetal lower obstructive uropathy. Lancet 346, 537–540 (1995).
Ruano, R. et al. Fetal cystoscopy for severe lower urinary tract obstruction—initial experience of a single center. Prenat. Diagn. 30, 30–39 (2010).
Quintero, R. A. et al. Percutaneous fetal cystoscopy and endoscopic fulguration of posterior urethral valves. Am. J. Obstet. Gynecol. 172, 206–209 (1995).
Welsh, A., Agarwal, S., Kumar, S., Smith, R. P. & Fisk, N. M. Fetal cystoscopy in the management of fetal obstructive uropathy: experience in a single European centre. Prenat. Diagn. 23, 1033–1041 (2003).
Morris, R. K., Ruano, R. & Kilby, M. D. Effectiveness of fetal cystoscopy as a diagnostic and therapeutic intervention for lower urinary tract obstruction: a systematic review. Ultrasound Obstet. Gynecol. 37, 629–637 (2011).
Morris, R. K. et al. Percutaneous vesicoamniotic shunting versus conservative management for lower urinary tract obstruction (PLUTO): a randomised trial. Lancet 382, 1496–1506 (2013).
Brown, C. et al. Effectiveness of percutaneous vesico-amniotic shunting in congenital lower urinary tract obstruction: divergence in prior beliefs among specialist groups. Eur. J. Obstet. Gynecol. Reprod. Biol. 152, 25–29 (2010).
Pritchard, K. I. et al. Clinical uses of Bayesian probability. Lancet 325, 993–994 (1985).
Lunn, D. J., Thomas, A., Best, N. & Spiegelhalter, D. WinBUGS—A Bayesian modelling framework: Concepts, structure, and extensibility. Statistics Computing 10, 325–337 (2000).
Biard, J. M. et al. Long-term outcomes in children treated by prenatal vesicoamniotic shunting for lower urinary tract obstruction. Obstet. Gynecol. 106, 503–508 (2005).
Denny, E., Quinlan-Jones, E., Bibila, S. & Kilby, M. D. The experience of pregnant women with a diagnosis of fetal lower urinary tract obstruction (LUTO). Midwifery http://dx.doi.org/10.1016/j.midw.2013.10.023.
The authors declare no competing financial interests.
About this article
Cite this article
Kilby, M., Morris, R. Fetal therapy for the treatment of congenital bladder neck obstruction. Nat Rev Urol 11, 412–419 (2014). https://doi.org/10.1038/nrurol.2014.132
This article is cited by
Comparison of outcomes of prenatal versus postnatal presentation of posterior urethral valves: a systematic review and meta-analysis
World Journal of Urology (2022)
Definition, diagnosis and management of fetal lower urinary tract obstruction: consensus of the ERKNet CAKUT-Obstructive Uropathy Work Group
Nature Reviews Urology (2022)
Maternal Health, Neonatology and Perinatology (2015)